No Data
No Data
Skye Bioscience GAAP EPS of -$0.20 Beats by $0.01
Skye Bioscience 2Q Loss/Shr 20c >SKYE
Express News | Skye Bioscience Reports Second Quarter 2024 Financial Results and Recent Highlights
SKYE BIOSCIENCE INC | 10-Q: Q2 2024 Earnings Report
Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Oppenheimer Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Maintains Target Price $21
No Data
Skinny bulldog OP : Look at the other company in the same industry you will know. The problem is, how high it can go.